Thousand Oaks, CA, United States of America

Clifford Goodman

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 16.7

ph-index = 5

Forward Citations = 96(Granted Patents)


Location History:

  • Thousand Oaks, CA (US) (2020 - 2023)
  • Calabasas, CA (US) (2024)

Company Filing History:


Years Active: 2020-2025

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):

Title: The Innovations of Clifford Goodman

Introduction

Clifford Goodman is a prominent inventor based in Thousand Oaks, CA, known for his significant contributions to the field of medical research. With a total of 8 patents to his name, Goodman has focused on developing innovative solutions for treating various types of cancer. His work has had a profound impact on the medical community and continues to influence cancer treatment methodologies.

Latest Patents

Goodman's latest patents include groundbreaking research on KRAS G12C inhibitors. These inhibitors are designed to target specific mutations associated with pancreatic, colorectal, and lung cancers. The patents detail the composition of these inhibitors and methods for their application, showcasing Goodman's commitment to advancing cancer treatment options.

Career Highlights

Throughout his career, Goodman has been associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to collaborate with other experts in the field and contribute to the development of innovative therapies. Goodman's dedication to research and development has positioned him as a key figure in the fight against cancer.

Collaborations

Goodman has worked alongside notable colleagues such as Brian Alan Lanman and Shon Booker. These collaborations have fostered an environment of innovation and have led to significant advancements in cancer treatment.

Conclusion

Clifford Goodman's contributions to the field of cancer research through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for new treatment options, making a lasting impact on the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…